Unknown

Dataset Information

0

Association between Galectin-3 levels within central and peripheral venous blood, and adverse left ventricular remodelling after first acute myocardial infarction.


ABSTRACT: Our study investigates association between Galectin-3 levels and adverse left ventricular remodelling (LVR) at six months. Fifty-seven patients following first acute myocardial infarction (AMI) were enrolled in this study and blood samples collected on day 1 from the femoral vein and artery, the right atrium near the coronary sinus and the aortic root, and on day 30, from the cubital vein. Patients with LVESV ?20% at six months, were included in the LVR group. On day 1, Galectin-3 plasma levels in the femoral vein (10.34?ng/ml?±?3.81 vs 8.22?ng/ml?±?2.34, p?=?0.01), and near coronary sinus (10.7?ng/ml?±?3.97 vs 8.41?ng/ml?±?2.56, p?=?0.007) were higher in the LVR group. Positive correlations between Galectin-3 levels from aortic root and coronary sinus, aortic root and femoral vein, and coronary sinus and femoral vein, were observed in both groups. On day 30, Galectin-3 concentration in the cubital vein was an independent risk factor of LVR six months post-AMI, demonstrating 1.5-fold increased risk. Day-30 Galectin-3 also showed positive correlations with echocardiography parameters indicative of diastolic and systolic dysfunction. Determining Galectin-3 plasma concentration on day 30 following AMI could have beneficial prognostic value in predicting LVR.

SUBMITTER: Andrejic OM 

PROVIDER: S-EPMC6739356 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Association between Galectin-3 levels within central and peripheral venous blood, and adverse left ventricular remodelling after first acute myocardial infarction.

Andrejic Olivera M OM   Vucic Rada M RM   Pavlovic Milan M   McClements Lana L   Stokanovic Dragana D   Jevtovic-Stoimenov Tatjana T   Nikolic Valentina N VN  

Scientific reports 20190911 1


Our study investigates association between Galectin-3 levels and adverse left ventricular remodelling (LVR) at six months. Fifty-seven patients following first acute myocardial infarction (AMI) were enrolled in this study and blood samples collected on day 1 from the femoral vein and artery, the right atrium near the coronary sinus and the aortic root, and on day 30, from the cubital vein. Patients with LVESV ≥20% at six months, were included in the LVR group. On day 1, Galectin-3 plasma levels  ...[more]

Similar Datasets

| S-EPMC8238704 | biostudies-literature
| S-EPMC7524135 | biostudies-literature
| S-EPMC8787983 | biostudies-literature
| S-EPMC6893492 | biostudies-literature
| S-EPMC3778959 | biostudies-literature
| S-EPMC7318996 | biostudies-literature
| S-EPMC5789971 | biostudies-other
| S-EPMC6208878 | biostudies-literature
| S-EPMC3345143 | biostudies-literature
2006-07-13 | E-GEOD-4648 | biostudies-arrayexpress